Precision Medicine Needs an Overhaul
PM360
AUGUST 26, 2024
Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. Cancer detection involves measurement of biomarkers, which leads to the application of targeted therapy (which targets specific cancer cells). All diseases are now “rare diseases”.
Let's personalize your content